Notes
NT-proB-type Natriuretic Peptide
Reference
Schnabel RB, et al. Refined atrial fibrillation screening and cost-effectiveness in the German population. Heart : 10 Aug 2021. Available from: URL: http://doi.org/10.1136/heartjnl-2020-318882
Rights and permissions
About this article
Cite this article
Single time-point AF screening does not appear to be cost effective in older patients in Germany. PharmacoEcon Outcomes News 886, 24 (2021). https://doi.org/10.1007/s40274-021-08002-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08002-4